Côd QR

Efficacy and safety of efavirenz in Niemann-Pick disease type C

Introduction: In search of disease-modifying treatments for the Niemann-Pick disease type C (NPC), this Phase II single-arm clinical trial evaluated the safety and efficacy of efavirenz, a reverse transcriptase inhibitor that potentially ameliorates neuronal cholesterol turnover, typically impaired...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Jordi Gascón-Bayarri, Inmaculada Rico, Cristina Sánchez-Castañeda, María Dolores Ledesma, Thiago Carnaval, Helena Bejr-Kasem, Jaume Campdelacreu, Anna Ferrer, Laura Rodríguez-Bel, Mónica Cos, Eugenia de Lama, Adolfo López de Munain, Idoia Rouco, Celia Pérez-Sousa, María Cerdán, Nuria Muelas, María Dolores Sevillano, Pablo Mir, Jesús Villoria, Sebastián Videla
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2025-09-01
Cyfres:Neurotherapeutics
Pynciau:
Clinical trial
Dementia
Lipid metabolism disorders
Lysosomal storage diseases
Neurodegenerative diseases
Neuropsychological tests
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S1878747925001849
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg